The Impact of Type 2 Diabetes on Circulating Adipokines in Patients with Metabolic Syndrome-Reference-Cited by-同舟云学术

The Impact of Type 2 Diabetes on Circulating Adipokines in Patients with Metabolic Syndrome

Published:2012 Issue:2 Volume:5 Page:270-276
ISSN:1662-4033
Container-title:Obesity Facts
language:en
Short-container-title:Obes Facts

Author:

Schindler Karin,Vila Greisa,Hoppichler Friedrich,Lechleitner Monika,Luger Anton,Anderwald Christian,Hoefler Jürgen,Tomasec Goran,Kautzky-Willer Alexandra,Ludvik Bernhard

Publisher

S. Karger AG

Subject

Physiology (medical),Health (social science)

Reference21 articles.

1. Harmonizing the Metabolic Syndrome

2. Epidemiology of Type 2 Diabetes and Cardiovascular Disease: Translation From Population to Prevention

3. Inflammation and metabolic disorders

4. Adipocytokines and the Metabolic Complications of Obesity

5. The release of the adipocytokine visfatin is regulated by glucose and insulin

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of serum visfatin and vaspin in hepatocellular carcinoma in hepatitis C-related liver cirrhosis;Clinical and Experimental Hepatology;2023

2. Sex-specific modulation of circulating growth differentiation factor-15 in patients with type 2 diabetes and/or obesity;Endocrine Connections;2022-07-01

3. NXNL1 negatively regulates osteoblast differentiation via GDF15‐induced PP2A Cα dependent manner in MC3T3‐E1 cells;BioFactors;2021-12-21

4. Associations Between Elevated Growth Differentiation Factor-15 and Sarcopenia Among Community-dwelling Older Adults;The Journals of Gerontology: Series A;2021-07-13

5. Effects of Exercise Intervention on Mitochondrial Stress Biomarkers in Metabolic Syndrome Patients: A Randomized Controlled Trial;International Journal of Environmental Research and Public Health;2021-02-24